TEST BANK A
Tietz Fundamentals Of
A A
CLINICAL CHEMISTRY AND
A A A
MOLECULAR DIAGNOSTICS A
7th Edition By Carl A. Burtis
A A A A A
TEST BANK A
,TietzAFundamentalsAofAClinicalAChemistryAandAMolecularADiagnosticsA7thA EditionATestABank
TableAofAcontents:
I.APrinciplesAOfALaboratoryAMedicine
ChapterA1.AClinicalAChemistry,AMolecularADiagnostics,AandALaboratoryAMedicine
ChapterA2.ASelectionAandAAnalyticalAEvaluationAofAMethodsA—AWithAStatisticalATechniques
ChapterA3.AClinicalAEvaluationAofAMethods
ChapterA4.AEvidence-BasedALaboratoryAMedicine
ChapterA5.AEstablishmentAandAUseAofAReferenceAValues
ChapterA6.ASpecimenACollection,AProcessing,AandAOtherAPreanalyticalAVariables
ChapterA7.AQualityAManagement
II.AAnalyticalATechniquesAAndAInstrumentation
ChapterA8.APrinciplesAofABasicATechniquesAandALaboratoryASafety
ChapterA9.AOpticalATechniques
ChapterA10.AElectrochemistryAandAChemicalASensors
ChapterA11.AElectrophoresis
ChapterA12.AChromatography
ChapterA13.AMassASpectrometry
ChapterA14.AEnzymeAandARateAAnalyses
ChapterA15.AImmunochemicalATechniques
ChapterA16AAutomation
ChapterA17.APoint-of-CareAInstrumentation
III.A Analytes
ChapterA18.AAminoAAcids,APeptides,AandAProteins
ChapterA19.ASerumAEnzymes
ChapterA20.ATumorAMarkersAandACancerAGenes
ChapterA21.AKidneyAFunctionATestsA—ACreatinine,AGFR,AUrea,AandAUricAAcid
ChapterA22.ACarbohydrates
ChapterA23.ALipids,ALipoproteins,AApolipoproteins,AandAOtherACardiacARiskAFactors
ChapterA24.AElectrolytesAandABloodAGases
ChapterA25.AHormones
ChapterA26.A CatecholaminesAandASerotonin
ChapterA27.A Vitamins,ATraceAElements,ANutritionalAAssessment
ChapterA28.AHemoglobin,AIron,AandABilirubin
ChapterA29.APorphyrinsAandAPorphyrias
ChapterA30.ATherapeuticADrugsAandATheirAManagement
ChapterA31.AClinicalAToxicology
ChapterA32.A ToxicAMetals
IV.A Pathophysiology
ChapterA33.ADiabetes
,ChapterA34.A CardiovascularADisease
ChapterA35.AKidneyADisease
ChapterA36.A PhysiologyAandADisordersAofAWater,AElectrolyte,AandAAcid-BaseAMetabolism
ChapterA37.A LiverADisease
ChapterA38.A GastrointestinalAandAPancreaticADiseases
ChapterA39.A DisordersAofABoneAandAMineralAMetabolism
ChapterA40.A DisordersAofAtheAPituitaryAGland
ChapterA41.A DisordersAofAtheAAdrenalACortex
ChapterA42.A ThyroidADisorders
ChapterA43.A Reproduction-RelatedADisorders
ChapterA44.A PregnancyAandAPrenatalATesting
ChapterA45.A NewbornAScreeningAandA InbornAErrorsAofAMetabolism
ChapterA46.APharmacogenetics
V.A MolecularADiagnostics
ChapterA47.APrinciplesAofAMolecularABiology
ChapterA48.ANucleicAAcidATechniquesAandAApplications
ChapterA49.AGenomesAandANucleicAAcidAAlterations
, TietzAFundamentalsAofAClinicalAChemistryAandAMolecularDiagnostics,A7eABurtisATestABank
ChapterA01:AClinicalAChemistry,AMolecularADiagnostics,AandALaboratoryAMedicineTestABa
nk
MULTIPLEACHOICE
1. AnAindividualAworkingAinAaAclinicalAchemistryAlaboratoryAisAmarriedAtoAaAsalesArepresentativ
eAwhoAworksAforAaAcompanyAthatAsellsAchemistryAlaboratoryAsupplies.AWhenAtheAlaboratoryA
managerArequestsAaAlistAofAneededAsupplies,AcostAofAsupplies,AandAvendors,AthisAindividualAon
lyArecommendsAtheAspouse’sAcompanyAasAtheAvendor.AThisAisAconsideredAtoAbeAa(n):
a. accountingAissue.
b. possibleAconflictAofAinterest.
c. maintenanceAofAconfidentialityAissue.
d. problemAwithAresourceAallocation.
ANS:A B
ConcernAhasAbeenAraisedAoverAtheAinterrelationshipsAbetweenApractitionersAinAtheAmedicalAfieldA
andAcommercialAsuppliersAofAdrugs,Adevices,Aequipment,Aetc.,AtoAtheAmedicalAprofession.
Similarly,ArelationshipsAhaveAbeenAscrutinizedAbetweenAclinicalAlaboratoriansAandAmanufactur
ersAandAprovidersAofAdiagnosticAequipmentAandAsupplies.ATheseAconcernsAledAtheANationalAInst
itutesAofAHealthA(NIH)AinA1995AtoArequireAofficialAinstitutionalAreviewAofAfinancialAdisclosureA
byAresearchersAandAmanagementAofAsituationsAinAwhichAdisclosureAindicatesApotentialAconflicts
AofAinterest.
DIF: 1 REF:A PageA4-5 OBJ:A 6A|A7
2. AApatientAvisitsAherAphysicianAstatingAthatAherAprescribedApainkillerAisAnotAworkingAtoAreduc
eAtheApainAfollowingAherArecentAsurgery.AAAfriendAofAtheApatientAclaimsAthatAtheAsameApainki
llerA“workedAwonders”AtoAreduceAherApainAafterAtheAsameAsurgery.ATheAphysicianAstatesAtha
tAtheAdifferenceAinAtheAeffectAofAtheAdrugAmightAbeAcausedAby
,AwhichAisAstudiedAinApharmacog
enetics.
a. epidemiology
b. anAinheritedAdisease
c. aAconflictAofAinterest
d. aAgeneticAvariationAinAdrug-metabolizingAenzymes
ANS:A D
PharmacogeneticsAisAtheAstudyAofAtheAgeneticAvariationAofAdrugAmetabolismAbetweenAindiv
iduals.
DIF: 1 REF:A A PageA3 OBJ:A 1
3. JohnAworksAinAaAmolecularAdiagnosticsAlaboratoryAandAreceivesAaAbloodAsampleAthatAhasAth
eAnameAofAaAcloseAfriendAprintedAonAtheAbar-
codedAlabel.ATheAgeneticAtestAthatAisAorderedAonAtheAfriend’sAsampleAwouldAprovideAdiagnos
ticAinformationAaboutAaAdisorderAthatAhasAaApoorAprognosis,AandAtheAtestAisAusuallyAperform
edAbyAJohn.AHeAasksAaAfellowAemployeeAtoAanalyzeAtheAsampleAforAhimAandAnotAdivulgeAthe
Aresults.AThisAethicalAissueAconcerns:
a. confidentialityAofApatientAgeneticAandAmedicalAinformation.
b. aAconflictAofAinterest.
c. resourceAallocation.
d. diagnosticAaccuracy.
Tietz Fundamentals Of
A A
CLINICAL CHEMISTRY AND
A A A
MOLECULAR DIAGNOSTICS A
7th Edition By Carl A. Burtis
A A A A A
TEST BANK A
,TietzAFundamentalsAofAClinicalAChemistryAandAMolecularADiagnosticsA7thA EditionATestABank
TableAofAcontents:
I.APrinciplesAOfALaboratoryAMedicine
ChapterA1.AClinicalAChemistry,AMolecularADiagnostics,AandALaboratoryAMedicine
ChapterA2.ASelectionAandAAnalyticalAEvaluationAofAMethodsA—AWithAStatisticalATechniques
ChapterA3.AClinicalAEvaluationAofAMethods
ChapterA4.AEvidence-BasedALaboratoryAMedicine
ChapterA5.AEstablishmentAandAUseAofAReferenceAValues
ChapterA6.ASpecimenACollection,AProcessing,AandAOtherAPreanalyticalAVariables
ChapterA7.AQualityAManagement
II.AAnalyticalATechniquesAAndAInstrumentation
ChapterA8.APrinciplesAofABasicATechniquesAandALaboratoryASafety
ChapterA9.AOpticalATechniques
ChapterA10.AElectrochemistryAandAChemicalASensors
ChapterA11.AElectrophoresis
ChapterA12.AChromatography
ChapterA13.AMassASpectrometry
ChapterA14.AEnzymeAandARateAAnalyses
ChapterA15.AImmunochemicalATechniques
ChapterA16AAutomation
ChapterA17.APoint-of-CareAInstrumentation
III.A Analytes
ChapterA18.AAminoAAcids,APeptides,AandAProteins
ChapterA19.ASerumAEnzymes
ChapterA20.ATumorAMarkersAandACancerAGenes
ChapterA21.AKidneyAFunctionATestsA—ACreatinine,AGFR,AUrea,AandAUricAAcid
ChapterA22.ACarbohydrates
ChapterA23.ALipids,ALipoproteins,AApolipoproteins,AandAOtherACardiacARiskAFactors
ChapterA24.AElectrolytesAandABloodAGases
ChapterA25.AHormones
ChapterA26.A CatecholaminesAandASerotonin
ChapterA27.A Vitamins,ATraceAElements,ANutritionalAAssessment
ChapterA28.AHemoglobin,AIron,AandABilirubin
ChapterA29.APorphyrinsAandAPorphyrias
ChapterA30.ATherapeuticADrugsAandATheirAManagement
ChapterA31.AClinicalAToxicology
ChapterA32.A ToxicAMetals
IV.A Pathophysiology
ChapterA33.ADiabetes
,ChapterA34.A CardiovascularADisease
ChapterA35.AKidneyADisease
ChapterA36.A PhysiologyAandADisordersAofAWater,AElectrolyte,AandAAcid-BaseAMetabolism
ChapterA37.A LiverADisease
ChapterA38.A GastrointestinalAandAPancreaticADiseases
ChapterA39.A DisordersAofABoneAandAMineralAMetabolism
ChapterA40.A DisordersAofAtheAPituitaryAGland
ChapterA41.A DisordersAofAtheAAdrenalACortex
ChapterA42.A ThyroidADisorders
ChapterA43.A Reproduction-RelatedADisorders
ChapterA44.A PregnancyAandAPrenatalATesting
ChapterA45.A NewbornAScreeningAandA InbornAErrorsAofAMetabolism
ChapterA46.APharmacogenetics
V.A MolecularADiagnostics
ChapterA47.APrinciplesAofAMolecularABiology
ChapterA48.ANucleicAAcidATechniquesAandAApplications
ChapterA49.AGenomesAandANucleicAAcidAAlterations
, TietzAFundamentalsAofAClinicalAChemistryAandAMolecularDiagnostics,A7eABurtisATestABank
ChapterA01:AClinicalAChemistry,AMolecularADiagnostics,AandALaboratoryAMedicineTestABa
nk
MULTIPLEACHOICE
1. AnAindividualAworkingAinAaAclinicalAchemistryAlaboratoryAisAmarriedAtoAaAsalesArepresentativ
eAwhoAworksAforAaAcompanyAthatAsellsAchemistryAlaboratoryAsupplies.AWhenAtheAlaboratoryA
managerArequestsAaAlistAofAneededAsupplies,AcostAofAsupplies,AandAvendors,AthisAindividualAon
lyArecommendsAtheAspouse’sAcompanyAasAtheAvendor.AThisAisAconsideredAtoAbeAa(n):
a. accountingAissue.
b. possibleAconflictAofAinterest.
c. maintenanceAofAconfidentialityAissue.
d. problemAwithAresourceAallocation.
ANS:A B
ConcernAhasAbeenAraisedAoverAtheAinterrelationshipsAbetweenApractitionersAinAtheAmedicalAfieldA
andAcommercialAsuppliersAofAdrugs,Adevices,Aequipment,Aetc.,AtoAtheAmedicalAprofession.
Similarly,ArelationshipsAhaveAbeenAscrutinizedAbetweenAclinicalAlaboratoriansAandAmanufactur
ersAandAprovidersAofAdiagnosticAequipmentAandAsupplies.ATheseAconcernsAledAtheANationalAInst
itutesAofAHealthA(NIH)AinA1995AtoArequireAofficialAinstitutionalAreviewAofAfinancialAdisclosureA
byAresearchersAandAmanagementAofAsituationsAinAwhichAdisclosureAindicatesApotentialAconflicts
AofAinterest.
DIF: 1 REF:A PageA4-5 OBJ:A 6A|A7
2. AApatientAvisitsAherAphysicianAstatingAthatAherAprescribedApainkillerAisAnotAworkingAtoAreduc
eAtheApainAfollowingAherArecentAsurgery.AAAfriendAofAtheApatientAclaimsAthatAtheAsameApainki
llerA“workedAwonders”AtoAreduceAherApainAafterAtheAsameAsurgery.ATheAphysicianAstatesAtha
tAtheAdifferenceAinAtheAeffectAofAtheAdrugAmightAbeAcausedAby
,AwhichAisAstudiedAinApharmacog
enetics.
a. epidemiology
b. anAinheritedAdisease
c. aAconflictAofAinterest
d. aAgeneticAvariationAinAdrug-metabolizingAenzymes
ANS:A D
PharmacogeneticsAisAtheAstudyAofAtheAgeneticAvariationAofAdrugAmetabolismAbetweenAindiv
iduals.
DIF: 1 REF:A A PageA3 OBJ:A 1
3. JohnAworksAinAaAmolecularAdiagnosticsAlaboratoryAandAreceivesAaAbloodAsampleAthatAhasAth
eAnameAofAaAcloseAfriendAprintedAonAtheAbar-
codedAlabel.ATheAgeneticAtestAthatAisAorderedAonAtheAfriend’sAsampleAwouldAprovideAdiagnos
ticAinformationAaboutAaAdisorderAthatAhasAaApoorAprognosis,AandAtheAtestAisAusuallyAperform
edAbyAJohn.AHeAasksAaAfellowAemployeeAtoAanalyzeAtheAsampleAforAhimAandAnotAdivulgeAthe
Aresults.AThisAethicalAissueAconcerns:
a. confidentialityAofApatientAgeneticAandAmedicalAinformation.
b. aAconflictAofAinterest.
c. resourceAallocation.
d. diagnosticAaccuracy.
